Enhancement of the CXCL12/CXCR4 axis due to acquisition of gemcitabine resistance in pancreatic cancer: effect of CXCR4 antagonists

Overview of attention for article published in BMC Cancer, May 2016

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (54th percentile)
Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

patent: 2 patents

Citations

dimensions_citation: 39 Dimensions

Readers on

mendeley: 23 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

GPCR HETEROMER INHIBITORS AND USES THEREOF

Application EP-3900712-A1

European Patent Office

MODIFIED IMMUNE CELLS AND USES THEREOF

Application EP-3373941-A4

European Patent Office

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.